Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the United States. However, Hill says it is “my hope…that by the year 2034 pancreatic cancer will no longer be a death sentence because federal funding will have provided for the development of novel therapies based on discoveries being made today about how this cancer grows.”
Hill, who is affiliated with the Mike and Josie Harper Cancer Research Institute at the University of Notre Dame, uses mouse models, human clinical samples, and assay systems to study the impact of the microenvironment on tumor growth and seeks to identify novel therapeutics that will have clinical relevance and can potentially change current treatment strategies for patients with pancreatic cancer.
Science 2034 is an initiative to consider the possibilities that science will bring in the next 20 years. It is led by the Science Coalition, a nonprofit and nonpartisan organization of the nation’s leading research universities, and is dedicated to sustaining federal support for research investment.
To read Hill’s full article, please visit Science 2034.